The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of ...

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

Richard Redett III, M.D., has been named physician-in-chief for Johns Hopkins Medicine (JHM) and vice dean for clinical ...

Analysts were unfazed by the news that Takeda will cease development of soticlestat after Phase III failures, while ...